BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23009152)

  • 21. Randomized controlled dissemination study of community-to-clinic navigation to promote CRC screening: Study design and implications.
    Larkey L; Szalacha L; Herman P; Gonzalez J; Menon U
    Contemp Clin Trials; 2017 Feb; 53():106-114. PubMed ID: 27940183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient Navigation in Medically Underserved Areas study design: A trial with implications for efficacy, effect modification, and full continuum assessment.
    Molina Y; Glassgow AE; Kim SJ; Berrios NM; Pauls H; Watson KS; Darnell JS; Calhoun EA
    Contemp Clin Trials; 2017 Feb; 53():29-35. PubMed ID: 27940186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography.
    Glassgow AE; Molina Y; Kim S; Campbell RT; Darnell J; Calhoun EA
    Health Promot Pract; 2019 Nov; 20(6):914-921. PubMed ID: 29907079
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient navigators' reflections on the navigator-patient relationship.
    Phillips S; Nonzee N; Tom L; Murphy K; Hajjar N; Bularzik C; Dong X; Simon MA
    J Cancer Educ; 2014 Jun; 29(2):337-44. PubMed ID: 24493636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program.
    Rice K; Gressard L; DeGroff A; Gersten J; Robie J; Leadbetter S; Glover-Kudon R; Butterly L
    Cancer; 2017 Sep; 123(17):3356-3366. PubMed ID: 28464213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.
    Ghebre RG; Jones LA; Wenzel JA; Martin MY; Durant RW; Ford JG
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1122-30. PubMed ID: 24643650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer peer navigation: an observational study on navigators' well-being, benefit finding, and program satisfaction.
    Vodermaier A; Kazanjian A; Soheilipour S; Flora P; Matthew A; Bender JL
    Support Care Cancer; 2023 Mar; 31(4):225. PubMed ID: 36947207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation.
    Ramirez AG; Gallion KJ; Perez A; Munoz E; Long Parma D; Moreno PI; Penedo FJ
    Contemp Clin Trials; 2019 Jan; 76():41-48. PubMed ID: 30399442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.
    Kim KE; Randal F; Johnson M; Quinn M; Maene C; Hoover S; Richmond-Reese V; K L Tangka F; Joseph DA; Subramanian S
    Cancer; 2018 Nov; 124(21):4137-4144. PubMed ID: 30359474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the feasibility, acceptability and effectiveness of a 'decision navigation' intervention for early stage prostate cancer patients in Scotland--a randomised controlled trial.
    Hacking B; Wallace L; Scott S; Kosmala-Anderson J; Belkora J; McNeill A
    Psychooncology; 2013 May; 22(5):1017-24. PubMed ID: 22570252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Navigation programs relevant for African American men with prostate cancer: a scoping review protocol.
    Palmer NR; Smith AN; Campbell BA; Andemeskel G; Tahir P; Felder TM; Cicerelli B
    Syst Rev; 2022 Jun; 11(1):122. PubMed ID: 35701771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating implementation of a community-focused patient navigation intervention at an NCI-designated cancer center using RE-AIM.
    Ver Hoeve ES; Calhoun E; Hernandez M; High E; Armin JS; Ali-Akbarian L; Frithsen M; Andrews W; Hamann HA
    BMC Health Serv Res; 2024 Apr; 24(1):550. PubMed ID: 38685006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The early dissemination of patient navigation interventions: results of a respondent-driven sample survey.
    Valverde PA; Calhoun E; Esparza A; Wells KJ; Risendal BC
    Transl Behav Med; 2018 May; 8(3):456-467. PubMed ID: 29800405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of patient navigation on satisfaction with cancer-related care.
    Wells KJ; Winters PC; Jean-Pierre P; Warren-Mears V; Post D; Van Duyn MA; Fiscella K; Darnell J; Freund KM;
    Support Care Cancer; 2016 Apr; 24(4):1729-53. PubMed ID: 26438146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.
    Ramachandran A; Freund KM; Bak SM; Heeren TC; Chen CA; Battaglia TA
    J Womens Health (Larchmt); 2015 Jan; 24(1):30-6. PubMed ID: 25513858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using specialist screening practitioners (SSPs) to increase uptake of bowel scope (flexible sigmoidoscopy) screening: results of a feasibility single-stage phase II randomised trial.
    McGregor LM; Skrobanski H; Ritchie M; Berkman L; Miller H; Freeman M; Patel N; Morris S; Rees C; von Wagner C
    BMJ Open; 2019 Feb; 9(2):e023801. PubMed ID: 30772850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of Cancer.
    Chavarri-Guerra Y; Soto-Perez-de-Celis E; Ramos-López W; San Miguel de Majors SL; Sanchez-Gonzalez J; Ahumada-Tamayo S; Viramontes-Aguilar L; Sanchez-Gutierrez O; Davila-Davila B; Rojo-Castillo P; Perez-Montessoro V; Bukowski A; Goss PE
    Oncologist; 2019 Sep; 24(9):1195-1200. PubMed ID: 30498134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
    Markossian TW; Darnell JS; Calhoun EA
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
    Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.
    Bensink ME; Ramsey SD; Battaglia T; Fiscella K; Hurd TC; McKoy JM; Patierno SR; Raich PC; Seiber EE; Warren-Mears V; Whitley E; Paskett ED; Mandelblatt S;
    Cancer; 2014 Feb; 120(4):570-8. PubMed ID: 24166217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.